CCNE1 and breast carcinoma: discovered that NE released by neutrophils internalized by breast cancer cells hydrolyzes cyclin E to generate an HLA-A2-restricted peptide (ILLDWLMEV), which is recognized by cytotoxic T lymphocytes (CTLs) to kill breast cancer cells (94).